Search for content, post, videos

Niox Mino gets approval in Japan

Swedish Aerocrine AB has announced that the Japanese authority has approved the FeNO measuring device Niox Mino.

On 28 of March 2013 the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) decided to grant the 2008 version of the Niox Mino marketing approval in Japan. As Aerocrine introduced a new version in 2010 of the product, the approval will have limited impact on the company’s sales in Japan in the near future, as stated in a press release.

“We look upon this approval as a positive regulatory milestone. We are very proud of being the first company to receive approval for the FeNO-method in Japan,” commented Tobias Bergenblad, Commercial Director Aerocrine for Asia.

Aerocrine’s Niox Mino is used to measure the concentration of nitric oxide in the exhaled breath, which is higher among people with asthma.